Kanoko Matsuyama

Activist fund ValueAct Capital Management LP said it’s looking forward to the opportunity to vote for new directors of Seven & i Holdings Co. after what it called a disappointing response from the retailer Thursday.

Japanese companies are selling record amounts of short-term bonds, a sign they’re bracing for the likelihood that the central bank will dismantle its ultra-low interest rate policy.

Hi, it’s Kanoko in Tokyo. My baby boomer parents are getting older and increasingly talking about how difficult it is to do things that was once second nature, like driving. But before we get to that...

Hi, it’s Kanoko in Tokyo, where scientists recently made a discovery that could spell good news for people who are allergic to eggs. But before we get to that...

Artificial intelligence can shave years off the development process, and companies like Japan’s Takeda are making large investments.

Hi, it’s Kanoko in Tokyo. Businesses across the world are investing heavily in the use of artificial intelligence — and the pharmaceutical industry is no exception. But before we get to that...

Eisai Co. is “very confident” of winning full approval from US regulators for its Alzheimer’s drug Leqembi, said Ivan Cheung, Eisai’s global Alzheimer’s disease officer.

Seven & i Holdings Co. will probably have enough votes to install its proposed slate of directors at its annual meeting this week and prevail over candidates from activist fund ValueAct Capital Management LP.

Top US and Japan commerce officials agreed to work together to explore the development of next generation semiconductors as part of efforts to maintain regional economic order.

Japan’s new JPX Prime 150 Index, which focuses on companies deemed to create value, will include Sony Group Corp., Keyence Corp. and Nippon Telegraph & Telephone Corp., according to a statement Friday.